Nobilis Health Corp. (NRTSF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 12, 2026
Nobilis Health Revenue
Nobilis Health had revenue of $69.19M in the quarter ending June 30, 2018, a decrease of -13.47%. This brings the company's revenue in the last twelve months to $282.58M, down -12.04% year-over-year. In the year 2017, Nobilis Health had annual revenue of $297.32M with 3.91% growth.
Revenue (ttm)
282.58M
Revenue Growth
-12.04%
P/S Ratio
n/a
Revenue / Employee
353.23K
Employees
900
Market Cap
78.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2017 | 297.32M | 11.19M | 3.91% |
| Dec 31, 2016 | 286.13M | 60.47M | 26.80% |
| Dec 31, 2015 | 225.66M | 141.63M | 168.55% |
| Dec 31, 2014 | 84.03M | 52.90M | 169.95% |
| Dec 31, 2013 | 31.13M | 10.38M | 50.00% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |